Monocyte chemoattractant protein 1 in obesity and insulin resistance. - Wikidata - awgldk - TriplyDB

Monocyte chemoattractant protein 1 in obesity and insulin resistance.

Monocyte chemoattractant protein 1 in obesity and insulin resistance.

http://www.wikidata.org/entity/Q35163496

about

MCP-1 upregulates amylin expression in murine pancreatic β cells through ERK/JNK-AP1 and NF-κB related signaling pathways independent of CCR2 Inflammation and insulin resistance Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications GPRC5B activates obesity-associated inflammatory signaling in adipocytes Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance Getting 'Smad' about obesity and diabetes Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment Obesity and cancer, a case for insulin signaling Potential Bioactive Compounds from Seaweed for Diabetes Management The role of obesity in gastrointestinal cancer: evidence and opinion Adipose tissue and adipocytes support tumorigenesis and metastasis Role of cytokines and chemokines in non-alcoholic fatty liver disease Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro Obesity is associated with macrophage accumulation in adipose tissue New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1 Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications The density of extracellular matrix proteins regulates inflammation and insulin signaling in adipocytes A Novel Selective Inhibitor of Delta-5 Desaturase Lowers Insulin Resistance and Reduces Body Weight in Diet-Induced Obese C57BL/6J Mice Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines Melanocortin receptors in rat liver cells: change of gene expression and intracellular localization during acute-phase response Fam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesis Increased oxidative stress in obesity and its impact on metabolic syndrome MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity Adipokines in inflammation and metabolic disease CCR2 modulates inflammatory and metabolic effects of high-fat feeding Nutritional approaches for managing obesity-associated metabolic diseases.The multiple faces of CCL13 in immunity and inflammation.The macrophage at the intersection of immunity and metabolism in obesity CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance.Spiral ligament fibrocyte-derived MCP-1/CCL2 contributes to inner ear inflammation secondary to nontypeable H. influenzae-induced otitis media.A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity.Connections between genetics and clinical data: Role of MCP-1, CFTR, and SPINK-1 in the setting of acute, acute recurrent, and chronic pancreatitis.Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway.Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice.Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice.Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.

P2860

Q21135461-78082FDF-D016-4185-AE64-875952245B4D Q22241893-E9B052E2-B6FB-4B98-8926-8D4D12C606EA Q22242884-DB855269-E55D-4C50-9545-14DD95F02795 Q24304291-D417A71E-8A86-470C-9250-C01035F58AF8 Q24617743-6BE46D1D-A4CB-4467-AF8A-6AC3738FCE11 Q24630117-2970E123-3E8B-419B-88C6-B20C1E27AD50 Q24645182-77C12959-5C13-43DE-89F8-1F36F0E74D6D Q25255189-3B9CCFCA-6407-40BF-BF2B-5919616697D5 Q26769963-67C2D2A7-A507-493E-AAE4-893FE115B5BA Q26771452-E8AACAE8-4EE5-4249-B6D4-A40EB2A817A7 Q26797339-A1635F5C-A329-4CD0-A8D8-8A1680633BA6 Q26825678-B0F748FF-881D-4DC0-9960-709963B82FDF Q26826123-9CA082E9-F202-4C56-AF3A-9F47BBC26246 Q26830328-A885AB5B-77F9-47A7-8D11-111FE6905D54 Q27324561-E466D632-F933-4BF1-805D-16292EB62489 Q27860976-DC2C2FB9-1AD3-4BC8-9C03-D5EA3CD19BE6 Q28070168-18F5B1B6-CB67-404A-B441-34092A1ED1F8 Q28085224-BC2C0611-0204-4DD9-96D5-FDED9BAC171E Q28261153-FF0CF37E-8A67-4605-9C99-FC0BA7771FA2 Q28469007-37DC1315-4FEC-427E-B885-D369C5B768F4 Q28505719-E56FAAAA-62D6-4345-B0F3-9D076594E8E6 Q28553462-C03B8E78-24E9-46CF-B7DC-DE9E500E9357 Q28566872-6CA1B91D-BC32-4EE8-AD85-691FC104B36F Q28573568-ADEE7070-2B3B-4780-B307-A0C9F546E632 Q28589295-6005F60C-11CD-487F-9D3B-D99AC5218CD5 Q29012150-938A34B8-C5F9-4D90-90B9-C29DF8572BA6 Q29614283-5943A23F-6A80-462D-9038-3E02493D896A Q29620456-3A8A05A3-D262-4FBF-9769-9B3AA1D7BAC3 Q29622869-16045B57-6A52-483F-B236-86438BFF7794 Q30234850-1F75C320-7BE2-4D03-ADC5-DC6DFC0361DB Q30352025-C412FCA4-B246-4BAE-BA70-67B80E9C4473 Q30408713-C1274578-561B-4C1E-94B8-56F256A424C1 Q30436563-A0347BB7-8B6B-42AD-9A4C-DE690B9E385A Q30478615-81B7FFC6-1B70-4E15-8C9E-987433047C8A Q33367128-FF044D9B-6916-4499-9EE3-ED6E2D9B0B65 Q33511586-2D83F55B-C8E9-4A1F-A7D7-CB1D3640F067 Q33553780-F93554A4-DDC7-4B92-A617-C6E61DCA30E5 Q33554780-0CFCEE51-088D-4D9E-8D4A-2E20B495B47F Q33559605-03035B61-6ABA-4E16-A3CA-C48835192DD2 Q33580624-2AC3AA33-F1BC-4E57-A8A3-F1C3663FAE15

P2860

Monocyte chemoattractant protein 1 in obesity and insulin resistance.

http://www.wikidata.org/entity/Q35163496

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Monocyte chemoattractant protein 1 in obesity and insulin resistance.

@ast

Monocyte chemoattractant protein 1 in obesity and insulin resistance.

@en

type

label

Monocyte chemoattractant protein 1 in obesity and insulin resistance.

@ast

Monocyte chemoattractant protein 1 in obesity and insulin resistance.

@en

prefLabel

Monocyte chemoattractant protein 1 in obesity and insulin resistance.

@ast

Monocyte chemoattractant protein 1 in obesity and insulin resistance.

@en

P1433

Q35163496-96F39A2F-2BD7-4952-8CC0-1729DD2C470B

P1476

Q35163496-69F83810-B7C1-4B38-A35E-1996896224D6

P2093

Q35163496-2261193E-E997-4EC3-B49F-FDD0FD5C1686

Q35163496-F3AAD911-4288-4786-9252-3321E54426F5

P2860

Q35163496-1096BCB3-9966-4202-A3DF-2AAD1D2FA039

Q35163496-1133301F-F29D-4233-BA49-0F7C87368FDE

Q35163496-1A8D0B38-E7E8-46BC-9757-50B0BAD7AD67

Q35163496-1EAAD786-E233-4381-B94E-D00AE4924CA0

Q35163496-1F69FF8B-5E95-42EF-ABBA-7585FF4B1991

Q35163496-25081F97-4ACE-4393-B54C-9C6F637613B2

Q35163496-25B76D41-446F-48C6-B772-BB694F23681B

Q35163496-29D2D305-09F8-4326-9187-B48DAFB93BF8

Q35163496-2F7F09F0-0595-4685-9307-2266A20E6707

Q35163496-31347941-9951-4280-8CCD-613D12CEFD18

P304

Q35163496-7C17F012-911A-464C-927B-8A12E5CC8B8B

P31

Q35163496-99FC082E-025C-4FEA-AD17-DAFFD4A65C7B

P356

Q35163496-EDEDBEC1-1730-4902-8D5A-22B9B0B84B42

P407

Q35163496-7C46FED1-177F-4620-88D1-E15D3E57DA94

P433

Q35163496-90E3C2F0-A10D-4895-8E5E-05805994B340

P478

Q35163496-8C15BAF0-F658-4C98-A87F-1FC31FBBE9A3

P577

Q35163496-0D3EF505-0E73-4F0A-9DE3-38262716BD57

P5875

Q35163496-695AFDBA-AB8E-4F5F-AF01-0F8CF374D233

P698

Q35163496-5A878870-5B3E-49B1-8875-81E2B6090CA2

P921

Q35163496-830833A7-E39E-4B64-A5A2-C3F311204997

Q35163496-C72B1A4B-EB6C-4AB7-B84C-519DA20A77AE

P932

Q35163496-A5E0FDCF-056E-4D81-A398-00FB3C19AACF

P356

PNAS.1133870100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Monocyte chemoattractant protein 1 in obesity and insulin resistance.

@en

P2093

David J Loskutoff

http://www.w3.org/2001/XMLSchema#string

Peter Sartipy

http://www.w3.org/2001/XMLSchema#string

P2860

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice

Chemokines and disease

Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice

Global and societal implications of the diabetes epidemic

Chemokines and leukocyte traffic

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus.

Through the looking glass: the diverse in vivo activities of chemokines.

Insulin: new roles for an ancient hormone.

P304

7265-7270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1133870100

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10752443

http://www.w3.org/2001/XMLSchema#string

P698

12756299

http://www.w3.org/2001/XMLSchema#string

P921

P932

165864

http://www.w3.org/2001/XMLSchema#string